This conference will bring together industry experts from leading RNA companies to discuss the challenges of clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies. The event will also give an overview of projects for RNA-based drugs that involve the modulation of gene and protein expression as well as genome editing.